Cart
sales@molnova.com
Ethyl 3-hexenoate
CAS No. 26553-46-8
Ethyl 3-hexenoate( —— )
Catalog No. M37378 CAS No. 26553-46-8
Ethyl 3-hexenoate is a volatile aroma component in pineapple and a RIFM fragrance. Currently, no genotoxicity and reproductive toxicity have been tested.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 30 | In Stock |
|
| 25MG | 46 | In Stock |
|
| 50MG | 62 | In Stock |
|
| 100MG | 88 | In Stock |
|
| 200MG | 128 | In Stock |
|
| 500MG | 213 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEthyl 3-hexenoate
-
NoteResearch use only, not for human use.
-
Brief DescriptionEthyl 3-hexenoate is a volatile aroma component in pineapple and a RIFM fragrance. Currently, no genotoxicity and reproductive toxicity have been tested.
-
DescriptionEthyl 3-hexenoate is a volatile aroma component in pineapple and a RIFM fragrance. Currently, no genotoxicity and reproductive toxicity have been tested.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number26553-46-8
-
Formula Weight142.2
-
Molecular FormulaC8H14O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC\C=C\CC(=O)OCC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Trimeprazine tartrat...
It is aphenothiazine derivative that is used as an antipruritic (it prevents itching from causes such as eczema or poison ivy, by acting as an antihistamine).
-
BV02
BV02 is an inhibitor of 14-3-3 protein-protein interactions and can be used in studies about the treatment of chronic myeloid leukemia. BV02 disrupts hematopoietic cells expressing the IM-resistant T315I mutation and the IM-sensitive wild-type Bcr-Abl.
-
EG1
EG1, a novel specific inhibitor of Pax2 transcription activation, targets the DNA binding domain and inhibits embryonic kidney development.
